01

October 01, 2026 To, The Manager Listing Department, The National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai – 400051 Dear Sir/ Madam, Trading Symbol: ZOTA Sub: Intimation of Acquisition of 39,228 equity shares of M/s Davaindia Health Mart Limited, Wholly Owned Subsidiary of the Company, by way of subscription to the right issue Ref.: Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 With reference to the captioned subject, we , M/s Zota Health Care Limited (the “Company”) would like to inform you that the Company has acquired 39,228 equity shares of M/s Davaindia Health Mart Limited, Wholly Owned Subsidiary (“WOS”) of the Company, by way of subscription to the right issue.

Page 1

02

Financial details: As per the audited financial statements for the Financial Year 202 5-26, the turnover of WOS was Rs. 267.71 crores.

Page 2

03

Whether the acquisition would fall within related party transaction(s) and whether the promoter/ promoter group/ group companies have any interest in the entity being acquired?

Page 2

04

If yes, nature of interest and details thereof and whether the same is done at “arm’s length” No, the acquisition does not fall within the ambit of related party transactions.

Page 2

05

Industry to which the entity being acquired belongs Pharmaceutical Objects and effects of acquisition (including but not limited to, disclosure of reasons for acquisition of target entity, if its business is outside the main line of business of the listed entity);

Page 2